Trial of PERL: A Multicenter Clinical Allopurinol to prevent GFR loss in T1D

Project: Research project

Project Details


Scope of Work Subcontractor under the direction of Dr. Molitch will provide personnel support for the PERL Clinical Trial entitled “PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR loss in T1D”. Staffing support funded by JDRF will successfully accomplish the necessary tasks of scheduling, organizing and maintaining the ongoing activities of the study including identifying and recruiting eligible patients for the PERL Clinical Trial.
Effective start/end date12/1/136/30/16


  • Joslin Diabetes Center, Inc. (17-2012-377//1944102-03)
  • JDRF International (17-2012-377//1944102-03)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.